Aghajanian GK (1995) Electrophysiology of serotonin receptor subtypes, signal transduction pathways. In: Bloom FR, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven, pp. 1451-1459 Applagate CD, Tecott LH (1998) Global increases in seizure susceptibility in mice lacking

5-HT2C receptors: a behavioral analysis. Exp Neurol 154(2):522-530 Azmitia EC, Whitaker-Azmitia, EC (1999) Development and adult plasticity of serotoninergic neurons and their target. In: Baumgarten HG, Göther M, eds. Serotonergic Neurons and 5-HT Receptors in the CNS. Springer: New York, pp. 1-39

Babb TL, Carr E, Crandall PH (1973) Analysis of extracellular firing patterns of deep temporal lobe structures in man. Electroencephalogr Clin Neurophysiol 34(3):247-257.

Bagdy G, Kecskemeti V, Riba P, Jakus R (2007) Serotonin and epilepsy. J Neurochem 100:857-873.

Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.

Becamel C, Figge A, Poliak S, et al (2001) Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 276:12974-12982

Bercovici E, Cortez MA, Wang X, Snead OC 3rd (2006) Serotonin depletion attenuates AY-9944-mediated atypical absence seizures. Epilepsia 47(2):240-246.

Bobker DH (1994) A slow excitatory postsynaptic potential mediated by 5-HT2 receptors in nucleus prepositus hypoglossi. J Neurosci 14:2428-2434.

Bonnycastle DD, Giarman NJ, Paasonen MK (1957) Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol 12(2):228-231.

Bragin A, Engel Jr J, Wilson CL, Vizentin E, Mathern GW (1999) Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia 40(9):1210-1221.

Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH (1997) Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat Genet 16:387-390.

Browne TR, Holmes GL (2003) Handbook of Epilepsy, 3rd ed. Philadelphia, PA: Lippinkott Williams &Wilkins.

Browning RA, Hoffman WE, Simonton RL (1978) Changes in seizure susceptibility after intrac-erebral treatment with 5,7-dihydroxy-tryptamine: role of serotonergic neurones. Ann NY Acad Sci 305:437-456.

Buterbaugh CG (1978) Effects of drugs modifying central serotonergic function on the response of extensor and non extensor rats to maximal electroshock. Life Sci 23:2393-2904.

Coenen AM, Drinkenburg WH, Inoue M, van Luijtelaar EL (1992) Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res 12(2):75-86.

D'Ambrosio R, Fender JS, Fairbanks JP, et al (2005) Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat. Brain 128:174-188.

Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC (1992) Effects of fluoxetine on convulsions and brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol 260:533-540.

Daily JW, Reigel CE, Mishura PK, Jobe PC (1989) Neurobiology seizure predisposition in the genetically epilepsy prone rat (Review). Epilepsy Res 3(1), 3-17.

Destexhe A, Bal T, McCormick DA, Sejnowski TJ (1996) Ionic mechanisms underlying synchronized oscillations and propagating waves in a model of ferret thalamic slices. J Neurophysiol 76(3):2049-2070.

Done CJ, Sharp T (1994) Biochemical evidence for regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 33:411-421.

Dube C, Richichi C, Bender RA, Chung G, Litt B, Baram TZ (2006) Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 129:911-922.

Engel J Jr (2004) Models of focal epilepsy. In: Hallett M, Phillips LH, Schomer DL II, Massey JM, eds. Advances in Clinical Neurophysiology. Clin Neurophysiol 57:392-399.

Fehr C, Shirly RL, Belknap JK, Crabbe JC, Buck KJ (2002) Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene. J Neurosci 22:3730-3738

Filakovszky J, Gerber K, Bagdy G (1999) A serotonin-1A receptor agonist and N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. Neurosci Lett 261:89-92.

Gerber K, Filakovszky J, Halasz P, Bagdy G (1998) The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 807:243-245.

Giaretta D, Avoli M, Gloor P (1987) Intracellular recordings in pericruciate neurons during spike and wave discharges of feline generalized penicillin epilepsy. Brain Res 405(1):68-79.

Gloor P (1978) Generalized epilepsy with bilateral synchronous spike and wave discharge. New findings concerning its physiological mechanisms. Electroencephalogr Clin Neurophysiol Suppl 34:245-249.

Goddard GV, McIntyre DC, Leech CK (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25(3):295-330.

Graf M, Jakus R, Kantor S, Levay G, Bagdy G (2004) Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett 359:45-48.

Halasz P, Terzano MG, Parrino L (2002) Spike-wave discharge and the microstructure of sleep-wake continuum in idiopathic generalised epilepsy, Neurophysiol Clin 32: 38-53.

Hernandez EJ, Williams PA, Dudek PA (2002) Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43(11):1337-1345.

Hiramatsu MK, Kawanaga K, Kabuto H, Mori A (1987) Reduced uptake and release of 5-hydroxytryptam-ine and taurine in the cerebral cortex of epileptic El mice. Epilepsy Res 1:40-44.

Holmes GL (2004) Models for generalized seizures. In: Hallett M, Phillips LH, Schomer DL II, Massey JM, eds. Advances in Clinical Neurophysiology (Clinical Neurophysiology Supplement, vol 57). The Netherlands: Elsevier BV, pp. 415-438.

Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain (Review). Trends Pharmacol Sci 10(4):130-132.

Hoyer D, Clarke DE, Fozrd JR, Harting PR, Mylecharane EJ, Saxena PR, Humpherey PPA (1994) VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.

Isaac M (2005) Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs. Curr Top Med Chem 5(1):59-64

Jäkälä P, Sirviö J, Koivisto E, Björklund M, Kaukua J, Riekkinen PJ (1995) Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Eur J Pharmacol 282:39-55.

Jakus R, Graf M, Juhasz G, Gerber K, Levay G, Halasz P, Bagdy G (2003) 5-HT2C receptors inhibit, 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp Neurol 182, 964-972.

Jobe PC, Picchioni AL, Chin L (1973) Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat. Life Sci 13(1):1-1.

Julius D, MacDermott AB, Axel R, et al (1988) Molecular characterisation of a functional cDNA encoding the serotonin1C receptor. Science 244:558-564

Kaminski RM, Van Rijn CM, Turski WA, Czuczwar SJ, Van Luijtelaar G (2001) AMPA and GABA(B) receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur J Pharmacol 430(2-3):251-259.

Kecskemeti V, Rusznak Z, Riba P, et al (2005) Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull 67:112-132.

Kharatishvili I, Nissinen JP, McIntosh TK, Pitkanen A (2006) A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140:685-697.

Kilian M, Frey HH (1973) Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 12:681-692.

Kullmann DM, Asztely F, Walker MC (2000) The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy (Review). Cell Mol Life Sci 57(11):1551-1561.

Löscher W (1984) Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs (Review). Methods Find Exp Clin Pharmacol 6(9):531-547

Löscher W (2002) Animal models of epilepsy for the development of antiepileptogenic and disease modifying drugs. A comparison of the pharmacology of kindling and post-status epilep-ticus models of temporal lobe epilepsy. Epilepsy Res 50:105-123.

Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145-181.

Matsumoto H, Ajmone-Marsan C (1964) Cellular mechanisms in experimental seizures. Science 144:193-194.

Mazarati AM, Baldwin RA, Shinmei S, Sankar R (2006) In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J Neurochem 95:1495-1503. McCormick DA (1992) Neurotransmitter actions in the thalamus and cerebral cortex. J Clin

Neurophysiol 9:212-223 McCormick DA (2002) Cortical and subcortical generators of normal and abnormal thythmicity.

Int Rev Neurobiol 49:99-114. McCormick DA, Wang Z (1991) Serotonin and noradrenaline excite GABAergic neurones of guinea-pig and cat nucleus reticularis thalami. J Physiol 442:235-255. Millan MJ, Marin P, Bockaert J, la Cour CM (2008) Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 29(9):454-64. Morimoto K, Fahnestock M, Racine RJ (2004) Kindling and status epilepticus models of epilepsy:

rewiring the brain. Prog Neurobiol 73:1-60. Morita K, Hamamoto M, Arai S, et al (2005) Inhibition of serotonin transporters by cocaine and meprylcaine through 5-HT2C receptor stimulation facilitates their seizure activities. Brain Res 1057(1-2):153-160

O'Dell LE, Li R, George FR, Ritz MC (2000) Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions. Brain Res 863(1-2):213-224. Palacios JM, Waeber C, Mengod G, et al (1991) Autoradiography of 5-HT receptors: a critical appraisal. Neurochem Int 18:17-25 Pape HC, McCormick DA (1989) Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarisation-activated cation current. Nature 340:715-718. Parker LL, Backstrom JR, Sanders-Bush E, Shiieh BH (2003) Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates its interaction with multiple PDZ protein 1. J Biol Chem 278:21576-21583 Prendiville S, Gale K (1993) Anticonvulsant effect of systemic fluoxetine on focally-evoked lim-

bic motor seizures in rats. Epilepsia 34:381-384. Przegalinski E (1985) Monoamines and the pathophysiology of seizure disorders. In: Frey HH, Janz D, eds. Handbook of Experimental Pharmacology. Berlin: Springer-Verlag, pp. 101-137. Przegalinski E, Baran J, Siwanowicz J (1994) Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl] piperazine-induced increase in threshold for maximal elec-troconvulsions in mice. Epilepsia 35:889-894 Radja F, Laporte AM, Daval G, et al (1991) Autoradiography of serotoin receptor subtypes in the central nervous system. Neurochem Int 18:1-15 Reilly MT, Milner LC, Shirley RL, Crabbe JC, Buck KJ (2008) 5-HT2C and GABAB receptors influence handling-induced convulsion severity in chromosome 4 congenic and BBA/2 J background strain mice. Brain Res 1198:124-131. Rick CE, Stanford IM, Lacey MG (1995) Excitation of rat substantia nigra pars reticulate neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptam-ine2C receptors. Neuroscience 69:903-913 Sanders-Bush E, Burris KD, Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924-928 Sheldon PW, Aghajanian GK (1991) Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse 9(3):208-218. Snead OC 3rd (1995) Basic mechanisms of generalized absence seizures. Ann Neurol 37:146-157.

Statnick MA, Maring-Smith ML, Clough RW, et al (1996) Effects of 5,7-dihydroxy-tryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci 59:1763-1771. Steriade M, McCormick DA, Sejnowski J (1993) Thalamocortical oscillacions in sleeping and arousal brain. Science 262:679-685. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546.

Upton N, Stean T, Middlemiss D, Blackburn T, Kennett G (1998) Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur J Pharmacol 359:33-40.

Van Luijtelaar EL, Drinkenburg WH, van Rijn CM, Coenen AM (2002) Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects? Methods Find Exp Clin Pharmacol 24(suppl D):65-70.

Van Wijngaarden I, Tulp MT, Soudijn W (1990) The concept of selectivity in 5-HT receptor research (Review). Eur J Pharmacol 188(6):301-312.

Velasco M, Velasco F, Velasco AL, Jimenez F, Brito F, Marquez I (2000) Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control (Review). Arch Med Res 31(3): 304-315.

Wada Y, Nakamura M, Hasegawa H, Yamaguchi N (1993) Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett 159(1-2):179-182.

Wada Y, Shiraishi J, Nakamura M, Koshino Y (1996) Biphasic action of the histamine precursor L-histidine in the rat kindling model of epilepsy. Neurosci Lett 204(3):205-208.

Wada Y, Shiraishi J, Nakamura M, Koshino Y (1997) Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res 747:338-342

Ward AA Jr (1972) Topical convulsant metals. In: Purpura DP, Penry JK, Tower DB, Woodbury DM, Walter RD, eds. Experimental Models of Epilepsy: A Manual for the Laboratory Worker., New York: Raven, pp. 13-35

Watanabe K, Ashby Jr CR, Katsumori H, Minabe Y (2000) The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 398:239-246.

Welsh JP, Placantonakis DG, Warsetsky SI, Marquez RG, Bernstein L, Aicher SA (2002) The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv Neurol 89:307-329.

Yan QS, Jobe PC, Cheong JH, Ko KH, Dailey JW (1994) Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy prone rats. Naunyn-Schmiedebergs. Arch Pharmacol 350:149-152.

Defeat Drugs and Live Free

Defeat Drugs and Live Free

Being addicted to drugs is a complicated matter condition that's been specified as a disorder that evidences in the obsessional thinking about and utilization of drugs. It's a matter that might continue to get worse and become disastrous and deadly if left untreated.

Get My Free Ebook

Post a comment